First, we defined CD4 < 350 cells/μL as a time-to-event endpoint in HIV/AIDS progression, and we could not exclude the possibility that the standards of baseline CD4 count and progression CD4 count were so approach that the judgment of HIV/AIDS progression might be not specific enough. This evidence concerns the gene CD4 and AIDS.